<?xml version="1.0" encoding="UTF-8"?>
<p>In fitting our theoretical model to in vitro data, we estimated the within-host virus transmission rate (β) and the rate(s) of cellular acquisition to antiviral status (ρ or ρ + 
 <inline-formula>
  <math id="inf32">
   <mi>ε</mi>
  </math>
 </inline-formula>) (
 <xref rid="table1" ref-type="table">Table 1</xref>; 
 <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Under absent immune assumptions, ρ and 
 <inline-formula>
  <math id="inf33">
   <mi>ε</mi>
  </math>
 </inline-formula> were fixed at 0 while β was estimated; under induced immune assumptions, 
 <inline-formula>
  <math id="inf34">
   <mi>ε</mi>
  </math>
 </inline-formula> was fixed at 0 while ρ and β were estimated; and under constitutive immune assumptions, all three parameters (ρ, 
 <inline-formula>
  <math id="inf35">
   <mi>ε</mi>
  </math>
 </inline-formula>, and β) were simultaneously estimated for each cell-virus combination. Best fit parameter estimates for MOI=0.001 data are visualized in conjunction with β – ρ and β – 
 <inline-formula>
  <math id="inf36">
   <mi>ε</mi>
  </math>
 </inline-formula> bifurcations in 
 <xref ref-type="fig" rid="fig4">Figure 4</xref>; all general patterns were recapitulated at lower values for β on MOI=0.0001 trials (
 <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).
</p>
